Effectiveness of melatonin for sleep impairment post paediatric acquired brain injury: evidence from a systematic
Lisa-Jane Keegan1, Rosa Reed-Berendt, Elizabeth Neilly
1Programme in Clinical Psychology, Leeds Institute of Health Sciences, University of Leeds , Clarendon Road, Leeds LS2 9LJ , UK.
Insights
Melatonin shows promise for treating sleep problems in children with acquired brain injury (ABI). However, more high-quality research is needed to confirm its effectiveness and guide clinical practice.
Area of Science:
- Pediatric Neurology
- Sleep Medicine
- Neurorehabilitation
Background:
- Sleep impairment is a common challenge for children with acquired brain injury (ABI).
- Melatonin is a potential therapeutic agent for sleep disturbances.
Purpose of the Study:
- To systematically review existing literature on melatonin use for sleep impairment in pediatric ABI.
- To assess the quality of evidence supporting melatonin's efficacy in this population.
Main Methods:
- A comprehensive literature search was performed using advanced search strategies.
- Seven relevant studies were identified from an initial pool of 589 papers.
- Study quality and outcome measures were critically evaluated.
Main Results:
- A significant lack of high-quality evidence exists regarding melatonin for sleep issues post-pediatric ABI.
- Inconsistent methodologies were observed, including variations in dosage, outcome measures, and patient stratification.
- Key themes included variability in melatonin dosage, screening, outcome reporting, and lack of treatment stratification.
Conclusions:
- Preliminary evidence suggests melatonin may be beneficial for sleep disturbances in children with ABI.
- Further rigorous research is essential to establish definitive treatment guidelines.
- Recommendations for future clinical and research practices are provided.
Objective:
To retrieve and review all the relevant literature describing the administration of melatonin to treat impaired sleep in children following acquired brain injury (ABI).
Methods:
A systematic search and retrieval of the literature was conducted using advanced search techniques. The retrieval identified 589 papers, seven of which were relevant. Review/outcomes criteria were developed and study quality was determined.
Results:
There is paucity of high-quality evidence to support use of melatonin for sleep impairment post paediatric ABI. Variation in dosage, screening and outcome measures, data reporting and a lack of impairment delineation and treatment stratification were recurrent themes.
Conclusion:
Retrieved evidence for the effectiveness of melatonin for post paediatric ABI sleep impairment appears promising. There is a clear need for further study in this area to inform clinical and research practices. Recommendations are given.
Related Concept Videos
01:19Management of Insomnia
01:13Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:11Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...